Evidence map›Paper›PMID 20124106›Full record

ArticleArchives of general psychiatry2010

Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.

Martin A Kohli, Daria Salyakina, Andrea Pfennig, Susanne Lucae, Sonja Horstmann, Andreas Menke, Stefan Kloiber, Johannes Hennings, Bekh B Bradley, Kerry J Ressler and 4 more

Abstract read
In one paragraph

Article in Archives of general psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Neurotrophin signalling in the human nervous system.Frontiers in molecular neuroscience · 2023
    Review
  11. Modeling endophenotypes of suicidal behavior in animals.Neuroscience and biobehavioral reviews · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Article
  17. An Analysis of FiveDisease markers · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Martin A KohliMax Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, Germany. kohlim@mpipsykl.mpg.de
Daria Salyakina
Andrea Pfennig
Susanne Lucae
Sonja Horstmann
Andreas Menke
Stefan Kloiber
Johannes Hennings
Bekh B Bradley
Kerry J Ressler
Manfred Uhr
Bertram Müller-Myhsok
Florian Holsboer
Elisabeth B Binder
Max Planck Society · DEEmory University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
NCATS NIH HHS UL1 TR000454NCRR NIH HHS UL1 RR025008
6 · The paper itself

Abstract

contextA consistent body of evidence supports a role of reduced neurotrophic signaling in the pathophysiology of major depressive disorder (MDD) and suicidal behavior. Especially in suicide victims, lower postmortem brain messenger RNA and protein levels of neurotrophins and their receptors have been reported.

objectiveTo determine whether the brain-derived neurotrophic factor (BDNF) gene or its high-affinity receptor gene, receptor tyrosine kinase 2 (NTRK2), confer risk for suicide attempt (SA) and MDD by investigating common genetic variants in these loci.

designEighty-three tagging single-nucleotide polymorphisms (SNPs) covering the genetic variability of these loci in European populations were assessed in a case-control association design.

settingInpatients and screened control subjects.

participantsThe discovery sample consisted of 394 depressed patients, of whom 113 had SA, and 366 matched healthy control subjects. The replication studies comprised 744 German patients with MDD and 921 African American nonpsychiatric clinic patients, of whom 152 and 119 were positive for SA, respectively.

interventionsBlood or saliva samples were collected from each participant for DNA extraction and genotyping.

main outcome measuresAssociations of SNPs in BDNF and NTRK2 with SA and MDD.

resultsIndependent SNPs within NTRK2 were associated with SA among depressed patients of the discovery sample that could be confirmed in both the German and African American replication samples. Multilocus interaction analysis revealed that single SNP associations within this locus contribute to the risk of SA in a multiplicative and interactive fashion (P = 4.7 x 10(-7) for a 3-SNP model in the combined German sample). The effect size was 4.5 (95% confidence interval, 2.1-9.8) when patients carrying risk genotypes in all 3 markers were compared with those without any of the 3 risk genotypes.

conclusionsOur results suggest that a combination of several independent risk alleles within the NTRK2 locus is associated with SA in depressed patients, further supporting a role of neurotrophins in the pathophysiology of suicide.

Indexed as

Suicide, AttemptedBlack or African AmericanCase-Control StudiesFemaleGenetic MarkersGenotypeGermanyHumansLinkage DisequilibriumMajor Depressive DisorderMaleMiddle AgedPolymorphism, Single NucleotidePsychiatric Status Rating ScalesReceptor, trkBRegression AnalysisGenetic MarkersReceptor, trkB

Identifiers

PMID20124106
PMCPMC3696349
OpenAlexW2054219118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.